MARTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 12.495
EU - Europa 6.528
AS - Asia 6.403
SA - Sud America 1.091
AF - Africa 118
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.667
Nazione #
US - Stati Uniti d'America 12.147
IT - Italia 2.759
SG - Singapore 2.666
CN - Cina 1.757
DE - Germania 1.056
BR - Brasile 943
HK - Hong Kong 632
UA - Ucraina 551
FI - Finlandia 493
GB - Regno Unito 442
TR - Turchia 353
VN - Vietnam 346
NL - Olanda 226
CA - Canada 192
RU - Federazione Russa 192
SE - Svezia 145
ID - Indonesia 136
FR - Francia 130
MX - Messico 128
PL - Polonia 118
IN - India 116
RO - Romania 113
JP - Giappone 104
ZA - Sudafrica 65
AR - Argentina 60
ES - Italia 59
BD - Bangladesh 52
LT - Lituania 48
BE - Belgio 38
AT - Austria 33
IQ - Iraq 33
CZ - Repubblica Ceca 30
PK - Pakistan 30
AU - Australia 26
CH - Svizzera 25
AE - Emirati Arabi Uniti 20
EC - Ecuador 20
UZ - Uzbekistan 20
IR - Iran 19
MA - Marocco 17
PE - Perù 16
CL - Cile 15
CO - Colombia 15
IL - Israele 13
SA - Arabia Saudita 13
KR - Corea 11
PT - Portogallo 10
MY - Malesia 9
PH - Filippine 9
TH - Thailandia 9
HU - Ungheria 8
PY - Paraguay 8
AZ - Azerbaigian 7
DZ - Algeria 7
NP - Nepal 7
TW - Taiwan 7
DK - Danimarca 6
EG - Egitto 6
IE - Irlanda 6
KE - Kenya 6
KG - Kirghizistan 6
UY - Uruguay 6
VE - Venezuela 6
AL - Albania 5
GR - Grecia 5
PA - Panama 5
TN - Tunisia 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
OM - Oman 4
RS - Serbia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
EE - Estonia 3
HN - Honduras 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
EU - Europa 2
GT - Guatemala 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SN - Senegal 2
AD - Andorra 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
Totale 26.646
Città #
Singapore 1.546
Ashburn 1.474
Fairfield 1.078
Woodbridge 979
Santa Clara 691
Beijing 689
Hong Kong 618
Houston 612
Chandler 604
Munich 568
Dallas 540
Jacksonville 540
Seattle 428
Ann Arbor 393
Wilmington 389
Cambridge 378
Ferrara 314
Milan 297
Helsinki 261
Los Angeles 242
New York 223
Izmir 194
Princeton 158
Rome 145
Nanjing 142
Shanghai 138
Boardman 129
Ho Chi Minh City 107
San Diego 107
Jakarta 100
Warsaw 95
Hanoi 94
Turku 94
Tokyo 83
London 80
Bologna 79
São Paulo 79
Mexico City 77
The Dalles 71
Hefei 70
Redwood City 68
Chicago 64
Brooklyn 63
Buffalo 57
Falkenstein 52
Denver 50
Toronto 48
Johannesburg 45
Poplar 45
Florence 44
Bremen 43
Hebei 42
Montreal 42
Chennai 41
Orem 41
Shenyang 40
Stockholm 39
Moscow 38
Tianjin 38
Atlanta 37
San Francisco 37
Falls Church 36
Boston 34
Brussels 33
Frankfurt am Main 32
Rio de Janeiro 32
Amsterdam 31
Nuremberg 31
San Jose 30
Ankara 29
Naples 29
Nanchang 27
Norwalk 27
Washington 27
Mountain View 26
Ottawa 26
Jiaxing 25
Cagliari 24
Changsha 24
Curitiba 24
Council Bluffs 23
Querétaro 23
San Mateo 22
Jyväskylä 21
Phoenix 20
Auburn Hills 19
Brno 19
Turin 19
Leawood 18
Manchester 18
Padova 18
Tashkent 18
Verona 18
Augusta 17
North Bergen 17
Salt Lake City 17
Biên Hòa 16
Porto Alegre 15
Rancho Palos Verdes 15
Secaucus 15
Totale 16.795
Nome #
Effetti acuti di JWH-018 e dei suoi sostituti alogenati sulle funzioni sensori-motorie del topo 844
Dall’America all’Asia: Salvia divinorum e Mitragyna speciosa 797
Autoerotic death: un unusual case of lethal asphyxiophilia associated with autogynephilia 617
1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice 365
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 345
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 341
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 332
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence 295
Forensic DNA phenotyping: prediction of human externally visible traits in missing person identification 287
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 277
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: JWH-018 269
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 252
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 243
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 238
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 235
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 217
Un distillato Bohémienne tuttora famoso: l’assenzio 210
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 209
The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure 206
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 202
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels 198
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 197
Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications 193
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity 190
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease 189
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 188
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 188
Loss of cortical GABA terminals in Unverricht–Lundborg disease 187
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 187
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels 182
JWH-018 impairs sensorimotor functions in mice 180
Striatal Dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors 178
Changes of glutamatergic control of striatal acetylcholine release in experimental parkinsonism 177
Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington’s disease 177
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 176
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 175
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography–tandem mass spectrometry investigation 173
Antagonisti dei recettori NOP e loro usi terapeutici 172
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 172
Droghe da stupro: il GHB ed i suoi analoghi 171
Application of 13 loci STR multiplex for cannabis sativa genotyping 171
Choose the cause of death: a complex suicide 171
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors 170
Application of 13 loci STR multiplex for the cannabis sativa genotyping 170
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 169
Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice 169
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway 168
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands 168
Kindled seizure-evoked somatostatin release in the hippocampus: inhibition by MK-801 165
Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation 164
NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms 161
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 160
Cutaneous miRNAs expression in human hanging injuries 159
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 158
Novel Synthetic Opioids: The Pathologist's Point of View 158
Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats 157
Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice 157
DNA recovery from immunochromatographic membranes 157
Forensic DNA Phenotyping (FDP): A Prediction of Human Externally Visible Traits in Missing Person Identification 156
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 156
Ayahuasca: il vino dell'anima 154
Differential role of striatal and nigral D1receptors in the expression of L-DOPA induced dyskinesia and its neurochemical correlates 154
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 152
The synthetic cathinones MDPHP and MDPV: Comparison of the acute effects in mice, in silico ADMET profiles and clinical reports 148
Agonisti dei recettori NOP per il trattamento delle discinesie da levodopa; 147
Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro 145
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model 143
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat 141
Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish 141
Mrna profiling in casework analyses 141
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release 140
JWH-018 and its N-pentyl-halogenated derivates impair sensory motor functions in mice. 139
Reply to "MDPV-induced aggression in humans not established" 138
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: An electrophysiological study 137
Accidental Autoerotic Death: An Unusual Case of Lethal Asphyxiophilia Associated With Autogynephilia 134
Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat 133
In vitro and in vivo pharmaco-toxicological characterization of 1-cyclohexyl-x-methoxybenzene derivatives in mice: comparison with tramadol and PCP 133
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 132
Nociceptin/orphanin FQ receptors modulate locomotion and motor cortex excitability in adult Rats 132
Synthetic cannabinoid JWH-018 impairs object recognition memory in mice: behavioral and electrophysiological evidence 132
In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45 131
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum 128
Regulation of miRNAs as new tool for cutaneous vitality lesions demonstration in ligature marks in deaths by hanging 128
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 128
Novel therapeutic strategies for treatment of motor abnormalities in Parkinson’s disease: focus on opioid receptors 127
Trichocereuspachanoi: quando la globalizzazione minaccia la tradizione. 127
L-DOPA-induced modulation of GABA and glutamate release in the substantia nigra pars reticulata and globus pallidus in a rat model of dyskinesia 125
Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs 123
Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats 123
Nociceptin/orphanin FQ receptor antagonists as a novel therapeutic approach to Parkinson’s disease: interaction with levodopa 121
null 121
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin 118
Studio degli effetti acuti e cronici e delle proprietà d’abuso del cannabinoide sintetico JWH-018: un approccio multidisciplinare 117
Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe 117
Nociceptin/orphanin FQ modulates neurotransmitter release in the substantia nigra: Biochemical and behavioural outcome 116
L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors 116
Low-normal doses of methiopropamine induce aggressive behaviour in mice 116
Comparison of N-methyl-2-pyrrolidone (NMP) and the “date rape” drug GHB: behavioral toxicology in the mouse model 115
Nociceptin/orphanin FQ receptor antagonists reverse parkinsonism in MPTP-treated mice and non-human primates 114
Metabolic profile of the synthetic drug 4,4′-dimethylaminorex in urine by LC–MS-based techniques: selection of the most suitable markers of its intake 114
Totale 18.936
Categoria #
all - tutte 121.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.338
Totale 122.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.347 0 0 0 0 0 176 96 283 84 294 271 143
2021/20221.501 79 181 124 52 87 66 99 69 45 105 144 450
2022/20231.602 179 145 81 150 232 177 104 133 226 28 93 54
2023/20241.386 96 105 65 48 123 204 76 107 56 82 77 347
2024/20256.429 206 174 532 318 550 749 487 475 945 551 805 637
2025/20268.171 1.620 652 1.554 1.763 2.309 273 0 0 0 0 0 0
Totale 27.035